Family Planning: Long-Acting Reversible Contraceptives

Published May 8th, 2015

There remains a high unmet need for family planning for women in the developing world, who would like to protect themselves against unwanted pregnancies but do not have access to proven, safe, and appropriate interventions. This contributes to significant maternal and infant deaths. In 2012, CHAI negotiated an agreement to lower the price of long-acting reversible contraceptives from US$18 to US$8.50 per implant and is now accelerating the rollout of these products. This effort will save the lives of over 45,000 women, will prevent over 200,000 children from being stillborn, and will empower women to protect themselves from unwanted pregnancies. The agreement will save donors over US$420 million over six years.